Evidence map›Paper›PMID 26544689›Full record

ArticlePloS one2015

Developmental MYH3 Myopathy Associated with Expression of Mutant Protein and Reduced Expression Levels of Embryonic MyHC.

Malgorzata Pokrzywa, Michaela Norum, Johan Lengqvist, Mehrnaz Ghobadpour, Saba Abdul-Hussein, Ali-Reza Moslemi, Homa Tajsharghi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Malgorzata PokrzywaDepartment of Clinical and Medical Genetics, University of Gothenburg, Gothenburg, Sweden.
Michaela NorumDepartment of Clinical and Medical Genetics, University of Gothenburg, Gothenburg, Sweden.
Johan LengqvistProteomic Core Facility, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Mehrnaz GhobadpourDepartment of Clinical and Medical Genetics, University of Gothenburg, Gothenburg, Sweden.
Saba Abdul-HusseinDepartment of Pathology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ali-Reza MoslemiDepartment of Pathology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Homa TajsharghiDepartment of Clinical and Medical Genetics, University of Gothenburg, Gothenburg, Sweden.
University of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAn essential role for embryonic MyHC in foetal development has been found from its association with distal arthrogryposis syndromes, a heterogeneous group of disorders characterised by congenital contractions. The latter probably result from severe myopathy during foetal development. Lack of embryonic muscle biopsy material and suitable animal models has hindered study of the pathomechanisms linking mutations in MYH3 to prenatal myopathy. METHODS AND

resultsWe determined the pathomechanisms of developmental myopathy caused by recurrent p.Thr178Ile MYH3 heterozygosity, using patient-derived skeletal muscle cells in culture as an experimental disease model to emulate early embryonic development. These cultured cells were processed for discrimination and quantitative analysis of mutant and wild-type MYH3 alleles and MyHC transcripts, real-time RT-qPCR, sequence analysis, immunofluorescence microscopy, immunoblot, and proteomic assessments. Involvement of the ubiquitin proteasome system was investigated in patients with p.Thr178Ile mutations in MYH3 and MYH2. We found equal overall expression of mutant and wild-type MyHC mRNAs and proteins. Compared to the controls, however, expression of embryonic MyHC transcripts and proteins was reduced whereas expression of myosin-specific E3 ubiquitin ligase (MuRF1) was increased. We also found delayed myofibrillogenesis and atrophic myotubes but structured sarcomeres.

conclusionIn conclusion, this study suggests that developmental p.Thr178Ile MYH3 myopathy is associated with a combined pathomechanism of insufficient dosage of functional embryonic MyHC and production of mutant protein.

Indexed as

Gene Expression Regulation, DevelopmentalCell DifferentiationCytoskeletal ProteinsHumansInfantMuscle DevelopmentMuscle Fibers, SkeletalMuscle ProteinsMuscular DiseasesMutant ProteinsMyosin Heavy ChainsProtein IsoformsRNA, MessengerSarcomeresTranscription, GeneticTripartite Motif ProteinsCytoskeletal ProteinsMuscle ProteinsMutant ProteinsMYH3 polypeptide, humanMyosin Heavy ChainsProtein IsoformsRNA, MessengerTRIM63 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID26544689
PMCPMC4636365
OpenAlexW2110355036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.